< previous issue
next issue >
Poveda, Andres; Vermorken, Jan B
Molecular approaches to management of epithelial ovarian cancer
Bast, R. C.; Yu, Y.; Xu, F. -J.; Le, X. -F.; Mills, G. B.
Staging of early ovarian cancer and the impact of lymph node sampling
Trimbos, J. B.
Surgical versus chemical upfront debulking in advanced ovarian cancer
Pecorelli, S.; Favalli, G.
The impact of specialist training for surgery in ovarian cancer
Intravenous chemotherapy for ovarian cancer – the state of the art?
Kaye, S. B.
The role of intraperitoneal chemotherapy in epithelial ovarian cancer
Vermorken, J. B.
Optimum chemotherapy for ovarian cancer
Ozols, R. F.
New cytotoxics and non-cytotoxics in epithelial ovarian cancer
Eisenhauer, E. A.
Long term survival of patients with advanced ovarian cancer treated with intraperitoneal radioimmunotherapy
Epenetos, A. A.; Hird, V.; Lambert, H.; Mason, P.; Coulter, C.
Options for modulation of drug resistance in ovarian cancer
Arts, H. J. G.; Van Der Zee, A. G. J.; De Jong, S.; De Vries, E. G. E.
High dose chemotherapy with peripheral blood stem cell transplantation (PBSCT) in ovarian cancer
Ledermann, Jonathan A
Advanced ovarian cancer: update, remarks and conclusions on optimal therapy
Here are a few pages on the site that we think you may find useful: